Endometrial Cancer: New Biology Driving Research and Treatment
November 7-9, 2020
JW Marriott Marquis
Victoria L. Bae-Jump, University of North Carolina, Chapel Hill, North Carolina
Blake Gilks, University of British Columbia, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada
Douglas A. Levine, New York University Perlmutter Cancer Center, New York, New York
Endometrial cancer is the most common cancer of the female reproductive tract, and the third most common cause of death in cancers which only affect women. This AACR Special Conference on Endometrial Cancer will explore New Biology Driving Research and Treatment. A broad range of topics will be discussed, from basic research in model systems, exploration of cause, and early detection and characterization to novel immunologic therapies, precision, and targeted therapeutics. The Conference Cochairs have developed a program that will appeal to laboratory scientists as well as clinical oncologists, all for the commitment to understanding and eliminating endometrial cancer.
Professional Educational Grant
GlaxoSmithKlineView Exhibitor Prospectus Brochure
For information on tabletop exhibits, please contact [email protected]. Space is limited.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available